Natco Pharma has allotted 46,795 equity shares of Rs.2/- each under ESOP. Resultantly, the paid up share capital of the Company stand increased to 18, 22,33,130 equity sharesamounting in aggregate to Rs.36,44,66,260

Powered by Capital Market - Live News

Natco Pharma has launched Rivaroxaban molecule, under brand RPIGAT. Rivaroxaban is an anticoagulant medication used to treat and prevent blood clots. Rivaroxaban is currently sold by Bayer under brand name ofXarelto®, in the Indian market.

After successful previous launches of DABIGAT (Dabigatran) and APIGAT (Apixaban) by NATCO, this latest Rivaroxaban NOAC (Novel oral anti-coagulant) is in line with the Company's mission of affordable medicines accessible to all. NATCO has launched RPIGAT in four strengths- 20 mg, 15mg, 10 mg and 2.5 mg. The 20 mg strength is priced at an MRP of Rs 14.0 per tablet.

Powered by Capital Market - Live News

ICICI Prudential Life Insurance Company Ltd, Force Motors Ltd, Caplin Point Laboratories Ltd, Jubilant Foodworks Ltd are among the other stocks to see a surge in volumes on BSE today, 07 December 2020.

Natco Pharma Ltd clocked volume of 64232 shares by 10:48 IST on BSE, a 6.34 times surge over two-week average daily volume of 10134 shares. The stock gained 6.11% to Rs.976.25. Volumes stood at 5479 shares in the last session.

ICICI Prudential Life Insurance Company Ltd clocked volume of 4.57 lakh shares by 10:48 IST on BSE, a 4.88 times surge over two-week average daily volume of 93711 shares. The stock gained 2.53% to Rs.488.10. Volumes stood at 30911 shares in the last session.

Force Motors Ltd witnessed volume of 40401 shares by 10:48 IST on BSE, a 4.84 times surge over two-week average daily volume of 8346 shares. The stock increased 13.49% to Rs.1,429.75. Volumes stood at 24174 shares in the last session.

Caplin Point Laboratories Ltd registered volume of 57683 shares by 10:48 IST on BSE, a 4.4 fold spurt over two-week average daily volume of 13119 shares. The stock rose 5.63% to Rs.520.50. Volumes stood at 28073 shares in the last session.

Jubilant Foodworks Ltd clocked volume of 69898 shares by 10:48 IST on BSE, a 4.1 times surge over two-week average daily volume of 17065 shares. The stock lost 1.38% to Rs.2,526.85. Volumes stood at 19816 shares in the last session.

Powered by Capital Market - Live News

In addition, NATCO and Breckenridge have settled the patent litigation with Celgene (now part of Bristol-Myers Squibb) in the U.S. district court for this product,” the company said in a BSE filing made during market hours today.

Celgene, sells Pomalidomide Capsules under Brand name POMALYST, in the USA market which is indicated for the treatment of patients suffering from multiple myeloma cancer.

As per industry sales data, POMALYST had annual sales of $957 million during the twelve months ending September 2020.

Natco Pharma announced its September quarter earnings during market hours yesterday. It reported 70.1% jump in consolidated net profit to Rs 202.40 crore on a 65.2% increase in net sales to Rs 802.20 crore in Q2 FY21 over Q2 FY20.

Profit before tax in Q2 September 2020 stood at Rs 270.70 crore, up by 94.2% from Rs 139.40 crore in Q2 September 2019. Current tax outgo in the second quarter increased by 2.18 times to Rs 71.80 crore from Rs 32.80 crore in the same period last year.

Natco Pharma manufactures a comprehensive range of branded and generic dosage forms, bulk actives and intermediates for both Indian as well as International markets.

The scrip rose 0.20% to Rs 907.75 on the BSE. It traded in the range of 907 and 930 so far during the day.

Powered by Capital Market - Live News